Trial intelligence / Profile preview

CYT107 in Metastatic Breast Cancer

NCT01368107Phase 2Completed

Sponsor
Centre Léon Bérard
Start
Jun 2011
Primary completion
Sep 2013
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of recombinant human interleukin-7 in breast cancer, sponsored by Centre Léon Bérard. Started Jun 2011; status: completed.

02

Drugs

recombinant human interleukin-7
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01368107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01368107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call